IP Verse

Vaccination With Multiple Clades Of H5 Influenza A Virus

PatentPatent Analysis

EP2614835

NOVARTIS
Application Number
EP12198671A
Filing Date
Nov 25, 2008
Status
Revoked
Sep 9, 2022
Grant Date
Aug 21, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP4321157B1
EP3487881B1

Bibliography

The patent EP2614835B1 was granted to Novartis on Aug 21, 2019 following the initial filing on Nov 25, 2008 under the application number EP12198671A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXOSMITHKLINE BIOLOGICALSMay 20, 2020 -

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents